ACIONT

Table of contents:

The "ACIONT" trademark, serial number 76019556 , was filed on 4th of April 2000 with a mark drawing code of 1000 and its transaction date is 76019556. The attorney assigned is Brent T. Winder, attorney docket number 15655.0002B. Since 17th of August 2012, the document can be found in the L10 law office in the publication and issue section. The employee responsible is GOODSAID, IRA J and the date it was published for opposition on 06/18/2002. The status of the trademark was checked last on 08/17/2012.

The "ACIONT" trademark, serial number 85349673 , was filed on 17th of June 2011 with a mark drawing code of 3000 and its transaction date is 85349673. The attorney assigned is Brent T. Winder, attorney docket number 15655.0001. Since 27th of April 2012, the document can be found in the M50 law office in the publication and issue section. The employee responsible is CHHINA, KARANENDRA S and the date it was published for opposition on 07/24/2012. The status of the trademark was checked last on 04/27/2012.

The corresponded responsible for this trademark is BRENT T. WINDER, located at JONES WALDO HOLBROOK & MCDONOUGH PC, 170 S MAIN ST STE 1500, SALT LAKE CITY, UT 84101-1644.

The state or country where the trademark was organized is UT by Aciont Inc.. The legal entity type behing it is a Corporation, located at 350 West 800 North Suite 320, Salt Lake City, UT zip 84103.

GOODS AND/OR SERVICES
International Class - 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
U.S. Class044 - Dental, Medical, and Surgical Appliances
Class Status6 - Active
Status Date06/22/2011
Primary Code010
Goods codes
CC0000Color is not claimed as a feature of the mark.
DM0000The mark consists of a rounded tapered band divided substantially in the center by a smaller tapered band all over the word ACIONT.
GS0101Non-invasive ocular drug delivery devices and ocular therapy devices, namely, drug delivery applicators and corresponding iontophoresis-based dose controlling devices, using passive, alternating passive with electrical current, or electrical current to transport drugs and therapeutics across human and mammal membrane tissues for the purpose of treating eye conditions and diseases; drug delivery systems, namely gels, all for use in delivering pharmaceuticals and drugs into the body; drug delivery systems, namely, gels for medical and therapeutic use for the treatment of allergies, cancer, cardiovascular disorders, central nervous system disorders, dermatological disorders, diseases of the mouth, ear, nose and throat disorders, hair and nail disorders, diabetes, endocrinological disorders, gastrointestinal disorders, gynecological disorders, hematological disorders, hormonal disorders, hypogonadism, immune system disorders, malnutrition, menopause, obesity, ocular disorders, pulmonary and respiratory disorders, reproductive and fertility disorders, rheumatilogical disorders, infectious diseases, viruses, bacteriological disorders, fungal disorders, parasitic disorders, soft tissue disorders, substance abuse and addictions, urological disorders

DESIGN CODES:

  • 26.17.02 - Bands, wavy; Bars, wavy; Lines, wavy; Wavy line(s), band(s) or bar(s)
  • 26.17.06 - Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal
  • 26.17.09 - Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved
PROSECUTION HISTORY
DateDescriptionTypeCode
04/27/2012 ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND O - Outgoing Correspondence MAB2 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
04/27/2012 ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE O - Outgoing Correspondence ABN2 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
09/30/2011 NOTIFICATION OF NON-FINAL ACTION E-MAILED O - Outgoing Correspondence GNRN
09/30/2011 NON-FINAL ACTION E-MAILED F - First Action GNRT - NON-FINAL ACTION E-MAILED
09/30/2011 NON-FINAL ACTION WRITTEN R - Renewal CNRT - NON-FINAL ACTION WRITTEN
09/27/2011 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
06/23/2011 NOTICE OF DESIGN SEARCH CODE MAILED O - Outgoing Correspondence MDSC
06/22/2011 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS
06/21/2011 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM

The "ACIONT" trademark, serial number 85349696 , was filed on 17th of June 2011 with a mark drawing code of 4000 and its transaction date is 85349696. The attorney assigned is Brent T. Winder, attorney docket number 15655.0001. Since 27th of April 2012, the document can be found in the M50 law office in the publication and issue section. The employee responsible is CHHINA, KARANENDRA S and the date it was published for opposition on 07/24/2012. The date when we last checked the status of this trademark was 04/27/2012.

The corresponded responsible for this trademark is BRENT T. WINDER, located at JONES WALDO HOLBROOK & MCDONOUGH PC, 170 S MAIN ST STE 1500, SALT LAKE CITY, UT 84101-1644.

The state or country where the trademark was organized is UT by Aciont Inc.. The legal entity type behing it is a Corporation, located at 350 West 800 North Suite 320, Salt Lake City, UT zip 84103.

GOODS AND/OR SERVICES
International Class - 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
U.S. Class044 - Dental, Medical, and Surgical Appliances
Class Status6 - Active
Status Date06/22/2011
Primary Code010
Goods codes
GS0101Non-invasive ocular drug delivery devices and ocular therapy devices, namely, drug delivery applicators and corresponding iontophoresis-based dose controlling devices, using passive, alternating passive with electrical current, or electrical current to transport drugs and therapeutics across human and mammal membrane tissues for the purpose of treating eye conditions and diseases; drug delivery systems, namely gels, all for use in delivering pharmaceuticals and drugs into the body; drug delivery systems, namely, gels for medical and therapeutic use for the treatment of allergies, cancer, cardiovascular disorders, central nervous system disorders, dermatological disorders, diseases of the mouth, ear, nose and throat disorders, hair and nail disorders, diabetes, endocrinological disorders, gastrointestinal disorders, gynecological disorders, hematological disorders, hormonal disorders, hypogonadism, immune system disorders, malnutrition, menopause, obesity, ocular disorders, pulmonary and respiratory disorders, reproductive and fertility disorders, rheumatilogical disorders, infectious diseases, viruses, bacteriological disorders, fungal disorders, parasitic disorders, soft tissue disorders, substance abuse and addictions, urological disorders
PROSECUTION HISTORY
DateDescriptionTypeCode
04/27/2012 ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND O - Outgoing Correspondence MAB2 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
04/27/2012 ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE O - Outgoing Correspondence ABN2 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
09/30/2011 NOTIFICATION OF NON-FINAL ACTION E-MAILED O - Outgoing Correspondence GNRN
09/30/2011 NON-FINAL ACTION E-MAILED F - First Action GNRT - NON-FINAL ACTION E-MAILED
09/30/2011 NON-FINAL ACTION WRITTEN R - Renewal CNRT - NON-FINAL ACTION WRITTEN
09/27/2011 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
06/22/2011 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS
06/21/2011 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.